Cargando…
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
OBJECTIVE: Increased hepatic expression of dipeptidyl peptidase 4 (DPP4) is associated with non-alcoholic fatty liver disease (NAFLD). Whether this is causative for the development of NAFLD is not yet clarified. Here we investigate the effect of hepatic DPP4 overexpression on the development of live...
Autores principales: | Baumeier, Christian, Schlüter, Luisa, Saussenthaler, Sophie, Laeger, Thomas, Rödiger, Maria, Alaze, Stella Amelie, Fritsche, Louise, Häring, Hans-Ulrich, Stefan, Norbert, Fritsche, Andreas, Schwenk, Robert Wolfgang, Schürmann, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641684/ https://www.ncbi.nlm.nih.gov/pubmed/29031724 http://dx.doi.org/10.1016/j.molmet.2017.07.016 |
Ejemplares similares
-
Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice
por: Kammel, Anne, et al.
Publicado: (2016) -
DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity
por: Böhm, Anja, et al.
Publicado: (2017) -
Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer
por: Lutz, Stefan Zoltán, et al.
Publicado: (2022) -
Identification of MicroRNAs Associated with Prediabetic Status in Obese Women
por: Kovac, Leona, et al.
Publicado: (2023) -
Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance
por: Hörber, Sebastian, et al.
Publicado: (2021)